PRECISION BIOSCIENCES INC — Director's Dealing 2022

Nov 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-11-02

Reporting Person: Scimeca Dario (General Counsel and Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-02	Restricted Stock Units	$	A	165200	Acquired		Common Stock (165200)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.